Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

14 Nov 2005 12:18

Fulcrum Pharma PLC14 November 2005 FULCRUM PHARMA PLC ("the Company") Director Shareholding The Company was informed on 11 November 2005 that on 11 November 2005 Jon Courtand Geoffrey Smith, Executive Directors of the Company, each bought 250,000ordinary shares in the Company at 3.9p per share. As a result, Dr Court now holds 7,399,328 ordinary shares, representingapproximately 6.07% per cent. of the current issued share capital of the Companyand Mr Smith now holds 903,333 ordinary shares, representing approximately 0.74%per cent. of the current issued share capital of the Company. END This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.